cemka > Publications > 2019

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study

    BARBUT F, DAY N, BOUÉE S, YOUSSOUF A, GRANDVOINNET L, LALANDE V, COUTURIER J, ECKERT C

    Clin Microbiol Infect ; 2019;25(5):588-594

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Effectiveness of sequencing TKIs in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC): A French national medical-administrative claim database analysis

    GIRARD N, BOUEE S, MORO-SIBILOT D, EMERY C, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C

    Annals of Oncology ; 2019;30(5):v627-v628

  • SantĂ© publique

    Feedback on the transition to routine use of Connexin, a tool to improve city-hospital cooperation

    DUROCHER V, DUBURCQ A, PAMART R

    The European Journal of Public Health ; 2019;29(supp.4)

  • SantĂ© publique

    Mapping of early intervention programs for psychosis in France in 2018

    COUROUVE L, DUBURCQ A, GOZLAN G, MEUNIER-CUSSAC S, LECARDEUR L, KREBS MO

    The European Journal of Public Health ; 2019;29(supp.4)

  • Économie de la santĂ©

    Prise de position de la SociĂ©tĂ© Francophone du DiabĂšte (SFD) sur la prise en charge mĂ©dicamenteuse de l’hyperglycĂ©mie du patient diabĂ©tique de type 2

    DARMON P, BAUDUCEAU B, BORDIER L, CHARBONNEL B, COSSON E, DETOURNAY B, FONTAINE P, GRIMALDI A, GOURDY P, GUERCI B, HANAIRE H, PENFORNIS A, SCHEEN A

    MĂ©decine des Maladies MĂ©taboliques ; 2019;13(8):711-732

  • Économie de la santĂ©

    Prise de position de la Société Francophone du DiabÚte (SFD) : évaluation du rapport bénéfices-risques des inhibiteurs de SGLT2.

    BAUDUCEAU B, BORDIER L, BRINGER J, CHABRIER G, CHARBONNEL B, COSSON E, DARMON P, DETOURNAY B, FONTAINE P, GOURDY P, GRIMALDI A, GUERCI B, HANAIRE H, PENFORNIS A, RIVELINE J-P, SCHEEN A.

    MĂ©decine des Maladies MĂ©taboliques ; 2019;13(2):195-209

  • Économie de la santĂ©

    Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.

    DETOURNAY B, DEBOUVERIE M, PEREIRA O, SEYER D, SOUDAN M, COUROUVE L, JHOMA K, EPSTEIN J, GUILLEMIN F.

    Mult Scler Relat Disord ; 2019;36:101396

  • SantĂ© publique

    Expérimentation de la télé-expertise en cardiologie en Pays de la Loire.

    HERAULT T, DONIO V, COUROUVE L, CAILLARD J.-B.

    Santé publique ; 2019;31(6):789-796

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Profile of Women Initiated on Denosumab and Pattern of Use in a Restricted Postmenopausal Osteoporosis Indication: A French Database Analysis Over the Period 2013-2014.

    EMERY C, GOURMELEN J, FAGNANI F, SUZAN F, DESAMERICQ G, FARDELLONE P.

    Adv Ther ; 2019;36(4),969-975

  • SantĂ© publique

    The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report.

    HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.

    Digestive and Liver Disease ; 2019

  • Économie de la santĂ©

    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study

    HEQUET D, HUCHON C, SOILLY AL, ASSELAIN B, BERSENEFF H, TRICHOT C, COMBES A, ALVES K, NGUYEN T, ROUZIER R, BAFFERT S.

    PLoS One ; 2019;14(7)

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database

    BOURDIN A, FABRY-VENDRAND C, OSTINELLI J, AIT-YAHIA M, DARNAL E, BOUEE S, LAURENDEAU C, BUREAU I, GOURMELEN J, CHOUAID C.

    J Allergy Clin Immunol Pract ; 2019;7(5):1477-1487

  • Pharmaco-EpidĂ©miologie

    Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study

    DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.

    Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Migraine burden and costs in france: a nationwide claims database analysis of triptan users.

    DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.

    J Med Econ ; 2019;22(7):616-624

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.

    LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.

    J Med Econ ; 2019;22(7):698-705